APA (7th ed.) Citation

AJ, M., AB, C., A, R., N, W., L, G., ES, L., & A, P. (2024). A standing platform for cancer drug development using ctDNA-based evidence of recurrence. Nature reviews. Cancer, 24(11), 810. https://doi.org/10.1038/s41568-024-00742-2

Chicago Style (17th ed.) Citation

AJ, Medford, Carmeli AB, Ritchie A, Wagle N, Garraway L, Lander ES, and Parikh A. "A Standing Platform for Cancer Drug Development Using CtDNA-based Evidence of Recurrence." Nature Reviews. Cancer 24, no. 11 (2024): 810. https://doi.org/10.1038/s41568-024-00742-2.

MLA (9th ed.) Citation

AJ, Medford, et al. "A Standing Platform for Cancer Drug Development Using CtDNA-based Evidence of Recurrence." Nature Reviews. Cancer, vol. 24, no. 11, 2024, p. 810, https://doi.org/10.1038/s41568-024-00742-2.